MicroRNAs and Endothelial (Dys) Function

Journal of Cellular Physiology

Volumn 231, Issue 8, 2016, Pages 1638-1644

  Santulli, Gaetano ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN126 MICRORNA, HUMAN;

ANGIOGENESIS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HYPERTENSION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; ANIMAL; CARDIOVASCULAR DISEASES; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GENETIC THERAPY; HUMANS; HYPERTENSION; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION;

EID: 84952815522     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25276     Document Type: Short Survey

References (100)

1. Akhtar S, Hartmann P, Karshovska E, Rinderknecht FA, Subramanian P, Gremse F, Grommes J, Jacobs M, Kiessling F, Weber C, Steffens S, Schober A. 2015. Endothelial Hypoxia-Inducible Factor-1alpha Promotes Atherosclerosis and Monocyte Recruitment by Upregulating MicroRNA-19a. Hypertension 66:1220-1226.
2. Alexander RW. 2004. Getting stents to go with the flow. J Clin Invest 113:1532-1534.
3. Anderson DM, Anderson KM, Chang CL, Makarewich CA, Nelson BR, McAnally JR, Kasaragod P, Shelton JM, Liou J, Bassel-Duby R, Olson EN. 2015. A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell 160:595-606.
4. Andrews SJ, Rothnagel JA. 2014. Emerging evidence for functional peptides encoded by short open reading frames. Nat Rev Genet 15:193-204.
5. Berthod F. 2013. Fibroblasts and endothelial cells: the basic angiogenic unit. In: Santulli G, editor. Angiogenesis: Insights from a systematic overview. New York, NY: Nova Science Publisher. p 145-158.
6. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Hoydal M, Autore C, Russo MA, Dorn GW 2nd, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G. 2007. MicroRNA-133 controls cardiac hypertrophy. Nat. Med 13:613-618.
7. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, Kodzius R, Shimokawa K, Bajic VB, Brenner SE, Batalov S, Forrest AR, Zavolan M, Davis MJ, Wilming LG, Aidinis V, Allen JE, Ambesi-Impiombato A, Apweiler R, Aturaliya RN, Bailey TL, Bansal M, Baxter L, Beisel KW, Bersano T, Bono H, Chalk AM, Chiu KP, Choudhary V, Christoffels A, Clutterbuck DR, Crowe ML, Dalla E, Dalrymple BP, de Bono B, Della Gatta G, di Bernardo D, Down T, Engstrom P, Fagiolini M, Faulkner G, Fletcher CF, Fukushima T, Furuno M, Futaki S, Gariboldi M, Georgii-Hemming P, Gingeras TR, Gojobori T, Green RE, Gustincich S, Harbers M, Hayashi Y, Hensch TK, Hirokawa N, Hill D, Huminiecki L, Iacono M, Ikeo K, Iwama A, Ishikawa T, Jakt M, Kanapin A, Katoh M, Kawasawa Y, Kelso J, Kitamura H, Kitano H, Kollias G, Krishnan SP, Kruger A, Kummerfeld SK, Kurochkin IV, Lareau LF, Lazarevic D, Lipovich L, Liu J, Liuni S, McWilliam S, Madan Babu M, Madera M, Marchionni L, Matsuda H, Matsuzawa S, Miki H, Mignone F, Miyake S, Morris K, Mottagui-Tabar S, Mulder N, Nakano N, Nakauchi H, Ng P, Nilsson R, Nishiguchi S, Nishikawa S, Nori F, Ohara O, Okazaki Y, Orlando V, Pang KC, Pavan WJ, Pavesi G, Pesole G, Petrovsky N, Piazza S, Reed J, Reid JF, Ring BZ, Ringwald M, Rost B, Ruan Y, Salzberg SL, Sandelin A, Schneider C, Schonbach C, Sekiguchi K, Semple CA, Seno S, Sessa L, Sheng Y, Shibata Y, Shimada H, Shimada K, Silva D, Sinclair B, Sperling S, Stupka E, Sugiura K, Sultana R, Takenaka Y, Taki K, Tammoja K, Tan SL, Tang S, Taylor MS, Tegner J, Teichmann SA, Ueda HR, van Nimwegen E, Verardo R, Wei CL, Yagi K, Yamanishi H, Zabarovsky E, Zhu S, Zimmer A, Hide W, Bult C, Grimmond SM, Teasdale RD, Liu ET, Brusic V, Quackenbush J, Wahlestedt C, Mattick JS, Hume DA, Kai C, Sasaki D, Tomaru Y, Fukuda S, Kanamori-Katayama M, Suzuki M, Aoki J, Arakawa T, Iida J, Imamura K, Itoh M, Kato T, Kawaji H, Kawagashira N, Kawashima T, Kojima M, Kondo S, Konno H, Nakano K, Ninomiya N, Nishio T, Okada M, Plessy C, Shibata K, Shiraki T, Suzuki S, Tagami M, Waki K, Watahiki A, Okamura-Oho Y, Suzuki H, Kawai J, Hayashizaki Y, Consortium F, Group RGER, Genome Science G. 2005. The transcriptional landscape of the mammalian genome. Science 309:1559-1563.
8. Cengiz M, Karatas OF, Koparir E, Yavuzer S, Ali C, Yavuzer H, Kirat E, Karter Y, Ozen M. 2015. Differential expression of hypertension-associated micrornas in the plasma of patients with white coat hypertension. Medicine (Baltimore) 94:e693.
9. Chaabane C, Otsuka F, Virmani R, Bochaton-Piallat ML. 2013. Biological responses in stented arteries. Cardiovasc Res 99:353-363.
10. Chan YC, Khanna S, Roy S, Sen CK. 2011. miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J Biol Chem 286:2047-2056.
11. Charan Reddy K. 2015. Regulatory noncoding RNAs in cardiovascular disease: Shedding light on 'Dark Matter'. JCvD 3:301-307.
12. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES, Zhang C. 2009. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105:158-166.
13. Cimpean A, Ribatti D, Raica M. 2013. A Historical appraisal of angiogenesis assays since judah folkman and before. In: Santulli G, editor. Angiogenesis: Insights from a systematic overview. New York, NY: Nova Science Publisher. p 31-50.
14. Cirillo P, Pellegrino G, Conte S, Maresca F, Pacifico F, Leonardi A, Trimarco B. 2015. Fructose induces prothrombotic phenotype in human endothelial cells: A new role for "added sugar" in cardio-metabolic risk. J Thromb Thrombolysis 40:444-451.
15. Climent M, Quintavalle M, Miragoli M, Chen J, Condorelli G, Elia L. 2015. TGFbeta Triggers miR-143/145 Transfer From Smooth Muscle Cells to Endothelial Cells, Thereby Modulating Vessel Stabilization. Circ. Res 116:1753-1764.
16. Courboulin A, Ranchoux B, Cohen-Kaminsky S, Perros F, Bonnet S. 2015. MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer? Curr Opin Oncol.
17. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. 2009. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 284:3728-3738.
18. Duscha BD, Robbins JL, Kontos CD, Kraus WD, Annex BH. 2013. Angiogenesis in peripheral artery disease: an emerging therapy targeting skeletal muscle. In: Santulli G, editor. Angiogenesis: Insights from a systematic overview. New York, NY: Nova Science Publisher. p 99-134.
19. Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, Smith AV, Tobin MD, Verwoert GC, Hwang SJ, Pihur V, Vollenweider P, O'Reilly PF, Amin N, Bragg-Gresham JL, Teumer A, Glazer NL, Launer L, Zhao JH, Aulchenko Y, Heath S, Sober S, Parsa A, Luan J, Arora P, Dehghan A, Zhang F, Lucas G, Hicks AA, Jackson AU, Peden JF, Tanaka T, Wild SH, Rudan I, Igl W, Milaneschi Y, Parker AN, Fava C, Chambers JC, Fox ER, Kumari M, Go MJ, van der Harst P, Kao WH, Sjogren M, Vinay DG, Alexander M, Tabara Y, Shaw-Hawkins S, Whincup PH, Liu Y, Shi G, Kuusisto J, Tayo B, Seielstad M, Sim X, Nguyen KD, Lehtimaki T, Matullo G, Wu Y, Gaunt TR, Onland-Moret NC, Cooper MN, Platou CG, Org E, Hardy R, Dahgam S, Palmen J, Vitart V, Braund PS, Kuznetsova T, Uiterwaal CS, Adeyemo A, Palmas W, Campbell H, Ludwig B, Tomaszewski M, Tzoulaki I, Palmer ND, Aspelund T, Garcia M, Chang YP, O'Connell JR, Steinle NI, Grobbee DE, Arking DE, Kardia SL, Morrison AC, Hernandez D, Najjar S, McArdle WL, Hadley D, Brown MJ, Connell JM, Hingorani AD, Day IN, Lawlor DA, Beilby JP, Lawrence RW, Clarke R, Hopewell JC, Ongen H, Dreisbach AW, Li Y, Young JH, Bis JC, Kahonen M, Viikari J, Adair LS, Lee NR, Chen MH, Olden M, Pattaro C, Bolton JA, Kottgen A, Bergmann S, Mooser V, Chaturvedi N, Frayling TM, Islam M, Jafar TH, Erdmann J, Kulkarni SR, Bornstein SR, Grassler J, Groop L, Voight BF, Kettunen J, Howard P, Taylor A, Guarrera S, Ricceri F, Emilsson V, Plump A, Barroso I, Khaw KT, Weder AB, Hunt SC, Sun YV, Bergman RN, Collins FS, Bonnycastle LL, Scott LJ, Stringham HM, Peltonen L, Perola M, Vartiainen E, Brand SM, Staessen JA, Wang TJ, Burton PR, Artigas MS, Dong Y, Snieder H, Wang X, Zhu H, Lohman KK, Rudock ME, Heckbert SR, Smith NL, Wiggins KL, Doumatey A, Shriner D, Veldre G, Viigimaa M, Kinra S, Prabhakaran D, Tripathy V, Langefeld CD, Rosengren A, Thelle DS, Corsi AM, Singleton A, Forrester T, Hilton G, McKenzie CA, Salako T, Iwai N, Kita Y, Ogihara T, Ohkubo T, Okamura T, Ueshima H, Umemura S, Eyheramendy S, Meitinger T, Wichmann HE, Cho YS, Kim HL, Lee JY, Scott J, Sehmi JS, Zhang W, Hedblad B, Nilsson P, Smith GD, Wong A, Narisu N, Stancakova A, Raffel LJ, Yao J, Kathiresan S, O'Donnell CJ, Schwartz SM, Ikram MA, Longstreth WT, Jr., Mosley TH, Seshadri S, Shrine NR, Wain LV, Morken MA, Swift AJ, Laitinen J, Prokopenko I, Zitting P, Cooper JA, Humphries SE, Danesh J, Rasheed A, Goel A, Hamsten A, Watkins H, Bakker SJ, van Gilst WH, Janipalli CS, Mani KR, Yajnik CS, Hofman A, Mattace-Raso FU, Oostra BA, Demirkan A, Isaacs A, Rivadeneira F, Lakatta EG, Orru M, Scuteri A, Ala-Korpela M, Kangas AJ, Lyytikainen LP, Soininen P, Tukiainen T, Wurtz P, Ong RT, Dorr M, Kroemer HK, Volker U, Volzke H, Galan P, Hercberg S, Lathrop M, Zelenika D, Deloukas P, Mangino M, Spector TD, Zhai G, Meschia JF, Nalls MA, Sharma P, Terzic J, Kumar MV, Denniff M, Zukowska-Szczechowska E, Wagenknecht LE, Fowkes FG, Charchar FJ, Schwarz PE, Hayward C, Guo X, Rotimi C, Bots ML, Brand E, Samani NJ, Polasek O, Talmud PJ, Nyberg F, Kuh D, Laan M, Hveem K, Palmer LJ, van der Schouw YT, Casas JP, Mohlke KL, Vineis P, Raitakari O, Ganesh SK, Wong TY, Tai ES, Cooper RS, Laakso M, Rao DC, Harris TB, Morris RW, Dominiczak AF, Kivimaki M, Marmot MG, Miki T, Saleheen D, Chandak GR, Coresh J, Navis G, Salomaa V, Han BG, Zhu X, Kooner JS, Melander O, Ridker PM, Bandinelli S, Gyllensten UB, Wright AF, Wilson JF, Ferrucci L, Farrall M, Tuomilehto J, Pramstaller PP, Elosua R, Soranzo N, Sijbrands EJ, Altshuler D, Loos RJ, Shuldiner AR, Gieger C, Meneton P, Uitterlinden AG, Wareham NJ, Gudnason V, Rotter JI, Rettig R, Uda M, Strachan DP, Witteman JC, Hartikainen AL, Beckmann JS, Boerwinkle E, Vasan RS, Boehnke M, Larson MG, Jarvelin MR, Psaty BM, Abecasis GR, Chakravarti A, Elliott P, van Duijn CM, Newton-Cheh C, Levy D, Caulfield MJ, Johnson T, Tang H, Knowles J, Hlatky M, Fortmann S, Assimes TL, Quertermous T, Go A, Iribarren C, Absher D, Risch N, Myers R, Sidney S, Ziegler A, Schillert A, Bickel C, Sinning C, Rupprecht HJ, Lackner K, Wild P, Schnabel R, Blankenberg S, Zeller T, Munzel T, Perret C, Cambien F, Tiret L, Nicaud V, Proust C, Uitterlinden A, van Duijn C, Whitteman J, Cupples LA, Demissie-Banjaw S, Ramachandran V, Smith A, Folsom A, Morrison A, Chen IY, Bis J, Volcik K, Rice K, Taylor KD, Marciante K, Smith N, Glazer N, Heckbert S, Harris T, Lumley T, Kong A, Thorleifsson G, Thorgeirsson G, Holm H, Gulcher JR, Stefansson K, Andersen K, Gretarsdottir S, Thorsteinsdottir U, Preuss M, Schreiber S, Konig IR, Lieb W, Hengstenberg C, Schunkert H, Fischer M, Grosshennig A, Medack A, Stark K, Linsel-Nitschke P, Bruse P, Aherrahrou Z. et al. 2011. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478:103-109.
20. Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW, Investigators AI. 2015. Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease. N Engl J Med 373:1905-1915.
21. Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. 2010. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci USA 107:13450-13455.
22. Feng X, Tan W, Cheng S, Wang H, Ye S, Yu C, He Y, Zeng J, Cen J, Hu J, Zheng R, Zhou Y. 2015. Upregulation of microRNA-126 in Hepatic Stellate Cells May Affect Pathogenesis of Liver Fibrosis Through the NF-kappaB Pathway. DNA Cell Biol.
23. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D. 2008. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15:272-284.
24. Friese RS, Altshuler AE, Zhang K, Miramontes-Gonzalez JP, Hightower CM, Jirout ML, Salem RM, Gayen JR, Mahapatra NR, Biswas N, Cale M, Vaingankar SM, Kim HS, Courel M, Taupenot L, Ziegler MG, Schork NJ, Pravenec M, Mahata SK, Schmid-Schonbein GW, O'Connor DT. 2013. MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension. Hum Mol Genet 22:3624-3640.
25. Fu X, Guo L, Jiang ZM, Zhao LS, Xu AG. 2014. An miR-143 promoter variant associated with essential hypertension. Int J Clin Exp Med 7:1813-1817.
26. Gu Q, Wang B, Zhang XF, Ma YP, Liu JD, Wang XZ. 2014. Contribution of renin-angiotensin system to exercise-induced attenuation of aortic remodeling and improvement of endothelial function in spontaneously hypertensive rats. Cardiovasc Pathol 23:298-305.
27. Head GA, Gueguen C, Marques FZ, Jackson KL, Eikelis N, Stevenson ER, Lambert GW, Charchar FJ, Davern PJ. 2015. 6b.01: Effect of renal denervation on blood pressure and microrna 181a in hypertensive schlager mice. J Hypertension 33 Suppl 1:e76.
28. Hu J, Zeng L, Huang J, Wang G, Lu H. 2015. miR-126 promotes angiogenesis and attenuates inflammation after contusion spinal cord injury in rats. Brain Res 1608:191-202.
29. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C. 2007. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 100:1579-1588.
30. Karolina DS, Tavintharan S, Armugam A, Sepramaniam S, Pek SL, Wong MT, Lim SC, Sum CF, Jeyaseelan K. 2012. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab 97:E2271-2276.
31. Katz G, Pobezinsky LA, Jeurling S, Shinzawa M, Van Laethem F, Singer A. 2014. T cell receptor stimulation impairs IL-7 receptor signaling by inducing expression of the microRNA miR-17 to target Janus kinase 1. Sci Signal 7:ra 83.
32. Kim J, Kang Y, Kojima Y, Lighthouse JK, Hu X, Aldred MA, McLean DL, Park H, Comhair SA, Greif DM, Erzurum SC, Chun HJ. 2013. An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat Med 19:74-82.
33. Kipshidze N, Dangas G, Tsapenko M, Moses J, Leon MB, Kutryk M, Serruys P. 2004. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 44:733-739.
34. Kraak RP, de Boer HH, Elias J, Ambarus CA, van der Wal AC, de Winter RJ, Wykrzykowska JJ. 2015. Coronary Artery Vessel Healing Pattern, Short and Long Term, After Implantation of the Everolimus-Eluting Bioresorbable Vascular Scaffold. J Am Heart Assoc 4.
35. Kriegel AJ, Baker MA, Liu Y, Liu P, Cowley AW, Jr., Liang M. 2015. Endogenous microRNAs in human microvascular endothelial cells regulate mRNAs encoded by hypertension-related genes. Hypertension 66:793-799.
36. Lampri E, Elli I. 2013. Angiogenesis: something old, something new. In: Santulli G, editor. Angiogenesis: Insights from a systematic overview. New York, NY: Nova Science Publisher. p 1-30.
37. Lei Z, van Mil A, Brandt MM, Grundmann S, Hoefer I, Smits M, El Azzouzi H, Fukao T, Cheng C, Doevendans PA, Sluijter JP. 2015. MicroRNA-132/212 family enhances arteriogenesis after hindlimb ischaemia through modulation of the Ras-MAPK pathway. J Cell Mol Med 19:1994-2005.
38. Li D, Yang P, Xiong Q, Song X, Yang X, Liu L, Yuan W, Rui YC. 2010. MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells. J Hypertens 28:1646-1654.
39. Li S, Zhu J, Zhang W, Chen Y, Zhang K, Popescu LM, Ma X, Bond Lau W, Rong R, Yu X, Wang B, Li Y, Xiao C, Zhang M, Wang S, Yu L, Chen AF, Yang X, Cai J. 2011. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 124:175-184.
40. Li Y, Mao L, Gao Y, Baral S, Zhou Y, Hu B. 2015. MicroRNA-107 contributes to post-stroke angiogenesis by targeting Dicer-1. Sci Rep 5:13316.
41. Liao YC, Wang YS, Guo YC, Lin WL, Chang MH, Juo SH. 2014. Let-7g improves multiple endothelial functions through targeting transforming growth factor-beta and SIRT-1 signaling. J Am Coll Cardiol 63:1685-1694.
42. Liu X, Cheng Y, Yang J, Qin S, Chen X, Tang X, Zhou X, Krall TJ, Zhang C. 2013. Flank sequences of miR-145/143 and their aberrant expression in vascular disease: mechanism and therapeutic application. J Am Heart Assoc 2:e000407.
43. Liu Y, Luo F, Wang B, Li H, Xu Y, Liu X, Shi L, Lu X, Xu W, Lu L, Qin Y, Xiang Q, Liu Q. 2015. STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells. Cancer Lett.
44. Lu Z, Zhang W, Gao S, Jiang Q, Xiao Z, Ye L, Zhang X. 2015. MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA. Biochem Biophys Res Commun.
45. Luo Y, Dong HY, Zhang B, Feng Z, Liu Y, Gao YQ, Dong MQ, Li ZC. 2015. miR-29a-3p attenuates hypoxic pulmonary hypertension by inhibiting pulmonary adventitial fibroblast activation. Hypertension 65:414-420.
46. Marks AR. 2003. Sirolimus for the prevention of in-stent restenosis in a coronary artery. N Engl J Med 349:1307-1309.
47. Marques FZ, Booth SA, Charchar FJ. 2015. The emerging role of non-coding RNA in essential hypertension and blood pressure regulation. J Hum Hypertens 29:459-467.
48. Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD, Elton TS. 2007. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. J Biol Chem 282:24262-24269.
49. McDonald RA, Halliday CA, Miller AM, Diver LA, Dakin RS, Montgomery J, McBride MW, Kennedy S, McClure JD, Robertson KE, Douglas G, Channon KM, Oldroyd KG, Baker AH. 2015. Reducing in-stent restenosis: therapeutic manipulation of miRNA in vascular remodeling and inflammation. J Am Coll Cardiol 65:2314-2327.
50. Meloche J, Le Guen M, Potus F, Vinck J, Ranchoux B, Johnson I, Antigny F, Tremblay E, Breuils-Bonnet S, Perros F, Provencher S, Bonnet S. 2015. miR-223 reverses experimental pulmonary arterial hypertension. Am J Physiol Cell Physiol 309:C363-372.
51. Menghini R, Casagrande V, Cardellini M, Martelli E, Terrinoni A, Amati F, Vasa-Nicotera M, Ippoliti A, Novelli G, Melino G, Lauro R, Federici M. 2009. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120:1524-1532.
52. Miki K, Endo K, Takahashi S, Funakoshi S, Takei I, Katayama S, Toyoda T, Kotaka M, Takaki T, Umeda M, Okubo C, Nishikawa M, Oishi A, Narita M, Miyashita I, Asano K, Hayashi K, Osafune K, Yamanaka S, Saito H, Yoshida Y. 2015. Efficient detection and purification of cell populations using synthetic microRNA switches. Cell Stem Cell 16:699-711.
53. Nicoli S, Knyphausen CP, Zhu LJ, Lakshmanan A, Lawson ND. 2012. miR-221 is required for endothelial tip cell behaviors during vascular development. Dev Cell 22:418-429.
54. Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty KE, Lawson ND. 2010. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 464:1196-1200.
55. Nossent AY, Hansen JL, Doggen C, Quax PH, Sheikh SP, Rosendaal FR. 2011. SNPs in microRNA binding sites in 3'-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction. Am J Hypertens 24:999-1006.
56. Novák J, Olejníčková V, Tkáčová N, Santulli G. 2015. Mechanistic role of micrornas in coupling lipid metabolism and atherosclerosis. In: Santuli G, editor. microRNA: Basic science-from molecular biology to clinical practice, Vol. 1. New York: Springer. p 79-100.
57. Ohyagi-Hara C, Sawada K, Kamiura S, Tomita Y, Isobe A, Hashimoto K, Kinose Y, Mabuchi S, Hisamatsu T, Takahashi T, Kumasawa K, Nagata S, Morishige K, Lengyel E, Kurachi H, Kimura T. 2013. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin alpha5 expression. Am J Pathol 182:1876-1889.
58. Olivieri F, Bonafe M, Spazzafumo L, Gobbi M, Prattichizzo F, Recchioni R, Marcheselli F, La Sala L, Galeazzi R, Rippo MR, Fulgenzi G, Angelini S, Lazzarini R, Bonfigli AR, Bruge F, Tiano L, Genovese S, Ceriello A, Boemi M, Franceschi C, Procopio AD, Testa R. 2014. Age- and glycemia-related miR-126-3p levels in plasma and endothelial cells. Aging 6:771-787.
59. Pan Y, Liang H, Liu H, Li D, Chen X, Li L, Zhang CY, Zen K. 2014. Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. J Immunol (Baltimore, Md: 1950) 192:437-446.
60. Pankratz F, Bemtgen X, Zeiser R, Leonhardt F, Kreuzaler S, Hilgendorf I, Smolka C, Helbing T, Hoefer I, Esser JS, Kustermann M, Moser M, Bode C, Grundmann S. 2015. MicroRNA-155 Exerts Cell-Specific Antiangiogenic but Proarteriogenic Effects During Adaptive Neovascularization. Circulation 131:1575-1589.
61. Patella F, Leucci E, Evangelista M, Parker B, Wen J, Mercatanti A, Rizzo M, Chiavacci E, Lund AH, Rainaldi G. 2013. MiR-492 impairs the angiogenic potential of endothelial cells. J Cell Mol Med 17:1006-1015.
62. Popma JJ, Topol EJ. 1990. Factors influencing restenosis after coronary angioplasty. Am J Med 88:16N-24N.
63. Potus F, Graydon C, Provencher S, Bonnet S. 2014. Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series). Pulm Circ 4:175-184.
64. Roitbak T, Bragina O, Padilla JL, Pickett GG. 2011. The role of microRNAs in neural stem cell-supported endothelial morphogenesis. Vasc Cell 3:25.
65. Sahu BS, Sonawane PJ, Mahapatra NR. 2010. Chromogranin A: a novel susceptibility gene for essential hypertension. Cell Mol Life Sci 67:861-874.
66. Santulli G. 2013. Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts. JCvD 1:1-2.
67. Santulli G. 2014. Angiopoietin-like proteins: A comprehensive look. Front Endocrinol 5:4.
68. Santulli G. 2015a. A fleeting glimpse inside microRNA, epigenetics, and micropeptidomics. In: Santuli G, editor. microRNA: Basic science-from molecular biology to clinical practice, Vol. 1. New York: Springer. p 1-14.
69. Santulli G. 2015b. Exploiting microRNA specificity and selectivity: Paving a sustainable path towards precision medicine. In: Santuli G, editor. microRNA: Medical evidence-from molecular biology to clinical practice, Vol. 3. New York: Springer. p 5-16.
70. Santulli G, Basilicata MF, De Simone M, Del Giudice C, Anastasio A, Sorriento D, Saviano M, Del Gatto A, Trimarco B, Pedone C, Zaccaro L, Iaccarino G. 2011. Evaluation of the anti-angiogenic properties of the new selective alphaVbeta3 integrin antagonist RGDechiHCit. J Transl Med 9:7.
71. Santulli G, Ciccarelli M, Palumbo G, Campanile A, Galasso G, Ziaco B, Altobelli GG, Cimini V, Piscione F, D'Andrea LD, Pedone C, Trimarco B, Iaccarino G. 2009. In vivo properties of the proangiogenic peptide QK. J Transl Med 7:41.
72. Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G. 2012. CaMK4 gene deletion induces hypertension. J Am Heart Assoc 1:e001081.
73. Santulli G, Trimarco B, Iaccarino G. 2013. G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. High Blood Press Cardiovasc Prev 20:5-12.
74. Santulli G, Wronska A, Uryu K, Diacovo TG, Gao M, Marx SO, Kitajewski J, Chilton JM, Akat KM, Tuschl T, Marks AR, Totary-Jain H. 2014. A selective microRNA-based strategy inhibits restenosis while preserving endothelial function. J Clin Invest 124:4102-4114.
75. Schlosser K, Taha M, Deng Y, Jiang B, Stewart DJ. 2015. Discordant regulation of microRNA between multiple experimental models and human pulmonary hypertension. Chest 148:481-490.
76. Sequeira-Lopez ML, Weatherford ET, Borges GR, Monteagudo MC, Pentz ES, Harfe BD, Carretero O, Sigmund CD, Gomez RA. 2010. The microRNA-processing enzyme dicer maintains juxtaglomerular cells. J Am Soc Nephrol 21:460-467.
77. Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatzigeorgiou AG, Antonarakis SE. 2007. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81:405-413.
78. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. 1987. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316:701-706.
79. Stefanini GG, Holmes DR, Jr. 2013. Drug-eluting coronary-artery stents. N Engl J Med 368:254-265.
80. Suarez Y, Fernandez-Hernando C, Yu J, Gerber SA, Harrison KD, Pober JS, Iruela-Arispe ML, Merkenschlager M, Sessa WC. 2008. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci USA 105:14082-14087.
81. Sun HX, Zeng DY, Li RT, Pang RP, Yang H, Hu YL, Zhang Q, Jiang Y, Huang LY, Tang YB, Yan GJ, Zhou JG. 2012. Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase. Hypertension 60:1407-1414.
82. Tang H, Ayon RJ, Yuan JX. 2015. New insights into the pathology of pulmonary hypertension: implication of the miR-210/ISCU1/2/Fe-S axis. EMBO Mol Med 7:689-691.
83. Thayanithy V, Dickson EL, Steer C, Subramanian S, Lou E. 2014. Tumor-stromal cross talk: direct cell-to-cell transfer of oncogenic microRNAs via tunneling nanotubes. Transl Res 164:359-365.
84. Tijsen AJ, Pinto YM, Creemers EE. 2012. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol 303:H1085-1095.
85. Torella D, Gasparri C, Ellison GM, Curcio A, Leone A, Vicinanza C, Galuppo V, Mendicino I, Sacco W, Aquila I, Surace FC, Luposella M, Stillo G, Agosti V, Cosentino C, Avvedimento EV, Indolfi C. 2009. Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K. Am J Physiol Heart Circ Physiol 297:H2015-2025.
86. Tu Y, Liu L, Zhao D, Liu Y, Ma X, Fan Y, Wan L, Huang T, Cheng Z, Shen B. 2015. Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2. Sci Rep 5:13827.
87. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. 2011. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13:423-433.
88. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN. 2008. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15:261-271.
89. Wang Z, Yin B, Wang B, Ma Z, Liu W, Lv G. 2013. MicroRNA-210 promotes proliferation and invasion of peripheral nerve sheath tumor cells targeting EFNA3. Oncol Res 21:145-154.
90. Welten SM, Bastiaansen AJ, de Jong RC, de Vries MR, Peters EA, Boonstra MC, Sheikh SP, Monica NL, Kandimalla ER, Quax PH, Nossent AY. 2014. Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 increases neovascularization and blood flow recovery after ischemia. Circ Res 115:696-708.
91. Wijns WC, Krucoff MW. 2006. Increased mortality after implantation of first generation drug-eluting stents: seeing the smoke, where is the fire? Eur Heart J 27:2737-2739.
92. Wronska A, Kurkowska-Jastrzebska I, Santulli G. 2015. Application of microRNAs in diagnosis and treatment of cardiovascular disease. Acta Physiol 213:60-83.
93. Xin M, Small EM, Sutherland LB, Qi X, McAnally J, Plato CF, Richardson JA, Bassel-Duby R, Olson EN. 2009. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 23:2166-2178.
94. Yang Q, Jia C, Wang P, Xiong M, Cui J, Li L, Wang W, Wu Q, Chen Y, Zhang T. 2014. MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation. Int J Cardiol 177:925-934.
95. Yao S, Hu M, Hao T, Li W, Xue X, Xue M, Zhu X, Zhou F, Qin D, Yan Q, Zhu J, Gao SJ, Lu C. 2015. MiRNA-891a-5p mediates HIV-1 Tat and KSHV Orf-K1 synergistic induction of angiogenesis by activating NF-kappaB signaling. Nucleic Acids Res 43:9362-9378.
96. Yu PJ, Ferrari G, Pirelli L, Gulkarov I, Galloway AC, Mignatti P, Pintucci G. 2007. Vascular injury and modulation of MAPKs: a targeted approach to therapy of restenosis. Cell Signal 19:1359-1371.
97. Zhou J, Wang KC, Wu W, Subramaniam S, Shyy JY, Chiu JJ, Li JY, Chien S. 2011a. MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc Natl Acad Sci USA 108:10355-10360.
98. Zhou Q, Gallagher R, Ufret-Vincenty R, Li X, Olson EN, Wang S. 2011b. Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters. Proc Natl Acad Sci USA 108:8287-8292.
99. Zhou Q, Anderson C, Zhang H, Li X, Inglis F, Jayagopal A, Wang S. 2014. Repression of choroidal neovascularization through actin cytoskeleton pathways by microRNA-24. Mol Ther: J Am Soc Gene Therapy 22:378-389.
100. Zhuang G, Wu X, Jiang Z, Kasman I, Yao J, Guan Y, Oeh J, Modrusan Z, Bais C, Sampath D, Ferrara N. 2012. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J 31:3513-3523.